Asset Planning Services (Pennsylvania)’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-100
Closed 289
2018
Q1
$0 Hold
100
﹤0.01% 297
2017
Q4
$0 Hold
100
﹤0.01% 321
2017
Q3
$0 Hold
100
﹤0.01% 319
2017
Q2
$0 Hold
100
﹤0.01% 324
2017
Q1
$0 Hold
100
﹤0.01% 324
2016
Q4
$0 Hold
100
﹤0.01% 293
2016
Q3
$0 Buy
+100
New +$378 ﹤0.01% 304

Other funds holding OREX

Asset Planning Services (Pennsylvania)'s OREX Position: Q2 2018 in Review

Asset Planning Services (Pennsylvania) sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 100 shares.

Asset Planning Services (Pennsylvania) first reported a position in OREX in Q3 2016 and held it in 7 quarters. The position peaked at $0 in Q1 2018. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

  • Asset Planning Services (Pennsylvania) reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Asset Planning Services (Pennsylvania) sold 100 Orexigen Therapeutics, Inc. shares in Q2 2018.
  • Asset Planning Services (Pennsylvania) first reported a position in Orexigen Therapeutics, Inc. in Q3 2016 and held it in 7 quarters.
  • Asset Planning Services (Pennsylvania)'s Orexigen Therapeutics, Inc. position peaked at $0 in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q2 2018, filed 1 Aug 2018.